 sulindac regress rectal polyp famili adenomat polyposi famili adenomat polyposi sulindac-induc polyp regress sever author studi goal result random placebo-control double-blind crossov studi patient rectal polyp colectomi ileorect anastomosi patient sulindac mg/day placebo period wash-out phase patient compliant sulindac author complet patient complet patient regress polyp placebo author increas patient chang patient rel decreas patient number polyp differ sulindac placebo signific biopsi specimen polyp normal rectal mucosa patient author immunohistochem studi cellular prolifer index Ki monoclon antibodi Ki index begin end treatment period abl sulindac-induc modif Ki index author sulindac effect regress rectal polyp famili adenomat polyposi